NCT03384979View on ClinicalTrials.gov

Optimization of Contrast Agent Dose in CT With Lean Body Weight

PHASE4CompletedINTERVENTIONAL

Enrollment

274

Participants

Timeline

Start Date

December 18, 2017

Primary Completion Date

February 25, 2019

Study Completion Date

February 25, 2019

Conditions

Contrast Agent With Lean Body Weight

Interventions

DRUG

Iopamidol

Contrast agent will be adrministered intravenously using total body weight or lean body weight, calculated with bioelectrical impedance analysis balance.

Trial Locations (1)

20097

IRCCS Policlinico San Donato, San Donato Milanese

All Listed Sponsors

lead

IRCCS Policlinico S. Donato

OTHER

NCT03384979 - Optimization of Contrast Agent Dose in CT With Lean Body Weight | Biotech Hunter | Biotech Hunter